Cytek Biosciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $48,140 | $44,135 | $62,141 | $52,293 |
Gross Profit | 28,340 | 21,254 | 32,885 | 27,551 |
EBITDA | -11,362 | -14,298 | -263 | -4,215 |
EBIT | -17,111 | -3,306 | -7,275 | |
Net Income | -12,158 | -18,866 | -44,076 | -5,478 |
Net Change In Cash | 48,140 | 44,135 | 62,141 | 52,293 |
Free Cash Flow | -5,753 | -4,904 | -1,772 | -4,553 |
Cash | 73,846 | 65,665 | 90,853 | 93,281 |
Basic Shares | 129,460 | 128,704 | 128,166 | 127,547 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $201,493 | $200,453 | $193,015 | $164,036 |
Gross Profit | 104,460 | 111,106 | 109,426 | 100,974 |
EBITDA | -17,392 | 4,790 | -4,408 | 9,492 |
EBIT | -29,367 | -5,700 | -13,638 | 3,833 |
Net Income | -66,539 | -6,020 | -12,148 | 2,576 |
Net Change In Cash | 201,493 | 200,453 | 193,015 | 164,036 |
Cost of Revenue | -62,627 | |||
Free Cash Flow | -8,770 | 21,854 | 454 | -22,099 |
Cash | 90,853 | 98,716 | 167,299 | 296,601 |
Basic Shares | 127,745 | 130,611 | 135,283 | 138,562 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.09 |
2026-03-31 | -$0.10 |
2025-12-31 | -$0.04 |
2025-09-30 | -$0.04 |